文献速递皮肤肿瘤

莫氏手术与宽切缘切除治疗早期侵袭性黑色素瘤的生存比较

Comparison of Survival After Mohs Micrographic Surgery vs Wide Margin Excision for Early-Stage Invasive Melanoma.
PubMed 文献 · JAMA Dermatol · 2019-01-01

多因素Cox回归显示MMS与总生存小幅改善相关(HR 0.86,95%CI 0.76-0.97),倾向评分匹配分析结果一致(HR 0.82,95%CI 0.68-0.98)。

要点

  • MMS治疗AJCC-8 I期黑色素瘤与WME相比总生存小幅改善。
  • 倾向评分匹配后MMS生存获益仍存在(HR 0.82)。
  • 学术机构比非学术机构更倾向于使用MMS(OR 2.03)。

核心结论

  • 对于适当选择的AJCC-8 I期黑色素瘤,MMS可能是不牺牲患者生存的WME替代方案。

主要发现

  • 多因素Cox回归控制临床和肿瘤因素后,MMS与WME相比总生存小幅改善(HR 0.86;95%CI 0.76-0.97)。
  • 倾向评分匹配分析中MMS组生存仍小幅改善(HR 0.82;95%CI 0.68-0.98)。
  • 学术机构使用MMS的几率高于非学术机构(OR 2.03;95%CI 1.88-2.18)。

临床怎么用

  • 在适当选择的AJCC-8 I期黑色素瘤病例中,可考虑将MMS作为传统WME的替代方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Melanoma is among the most common malignant neoplasms in the United States, with 91 270 cases estimated to be diagnosed in 2018. Since 2012, Mohs micrographic surgery (MMS) has gained popularity in the treatment of melanoma in situ. Although current guidelines for invasive melanoma without nodal metastases recommend surgery with wide margin excision (WME), use of MMS for this disease has increased as well, particularly in early stages. How the survival outcomes after each procedure compare with one another for early-stage invasive melanoma is unknown to date. OBJECTIVE: To evaluate overall survival of patients with stage I melanoma defined by the American Joint Committee on Cancer Cancer Staging Manual, 8th edition (AJCC-8) after MMS vs traditional WME. DESIGN, SETTING, AND ANALYSIS: This retrospective cohort study includes all patients with AJCC-8 stage I melanoma who underwent MMS or WME in the National Cancer Database with a diagnosis from January 1, 2004, through December 31, 2014. The National Cancer Database includes all reportable cases from Commission on Cancer-accredited facilities and represents approximately 50% of all newly diagnosed melanoma cases in the United States. Data were analyzed from November 13, 2018, through June 9, 2019. EXPOSURES: MMS vs WME. MAIN OUTCOMES AND MEASURES: Overall survival evaluated using multivariable Cox proportional hazards regression analysis. RESULTS: A total of 70 319 eligible patients (52.3% male and 47.7% female; median [SD] age, 57.0 [16.2] years) were identified, including 67 085 treated with WME and 3234 treated with MMS. Multivariable Cox proportional hazards regression survival analysis controlling for clinical and tumor factors revealed that treatment with MMS was associated with a modest improvement in overall survival relative to WME (hazard ratio [HR], 0.86; 95% CI, 0.76-0.97). Propensity score-matched analysis of cohorts of patients treated with MMS vs WME also found modestly improved survival for those treated with MMS (HR, 0.82; 95% CI, 0.68-0.98). Academic facilities were more likely to use MMS than nonacademic facilities (odds ratio, 2.03; 95% CI, 1.88-2.18). CONCLUSIONS AND RELEVANCE: These findings suggest that Mohs surgery may provide an alternative approach to traditional WME for appropriately selected cases of AJCC-8 stage I melanoma without compromising patient survival.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Cheraghlou S, Christensen SR, Agogo GO, et al. Comparison of Survival After Mohs Micrographic Surgery vs Wide Margin Excision for Early-Stage Invasive Melanoma. JAMA Dermatol. 2019. PMID: 31553403. doi:10.1001/jamadermatol.2019.2890

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。